Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/34079
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBATEN, Evert-
dc.contributor.authorVan der Aa, F.-
dc.contributor.authorGOETHUYS, Hans-
dc.contributor.authorSlabbert, K.-
dc.contributor.authorARIJS, Ingrid-
dc.contributor.authorVAN RENTERGHEM, Koenraad-
dc.date.accessioned2021-05-26T13:11:41Z-
dc.date.available2021-05-26T13:11:41Z-
dc.date.issued2021-
dc.date.submitted2021-05-25T12:44:56Z-
dc.identifier.citationWorld Journal of Urology, 39 (10), p. 3839-3844-
dc.identifier.issn0724-4983-
dc.identifier.urihttp://hdl.handle.net/1942/34079-
dc.description.abstractPurpose To determine whether omitting antimicrobial prophylaxis (AMP) in TURB is safe in patients undergoing TURB without an indwelling pre-operative catheter/nephrostomy/DJ and a negative pre-operative urinary culture. Materials and methods A multi-centered randomized controlled trial (RCT) from 17-09-2017 to 31-12-2019 in 5 hospitals. Patients with a pre-operative indwelling catheter/DJ-stent or nephrostomy and a positive pre-operative urinary culture (> 10(4) uropathogens/mL) were excluded. Post-operative fever was defined as body temperature >= 38.3 degrees C. A non-inferiority design with a 6% noninferiority margin and null hypothesis (H0) that the infection risk is at least 6% higher in the experimental (E) than in the control (C) group; H0: C (AMP-group) - E (no AMP-group) >= Delta (6% noninferiority margin). A multivariable, logistic regression was performed for AMP and post-TURB fever with covariates: tumor size and (clot-) retention. The R Project(R) for statistical computing was used for statistical analysis and a p value of 0.05 was considered as statistically significant. Results 459 Patients were included and 202/459 (44.1%) received AMP vs 257/459 (55.9%) without AMP. Fever occurred in 6/202 [2.9%; 95% CI (1.2-6.6%)] patients with AMP vs 8/257 [3.1%; 95% CI (1.5%-6.1%)] without AMP (p = 0.44). Multivariable, logistic regression showed no significant harm in omitting AMP when controlled for (clot-)retention and tumor size (p = 0.85) and an adjusted risk difference in developing post-TURB fever of 0.0016; 95% CI [- 0.029; 0.032]. Conclusion Our data suggest the safety of omitting AMP in patients undergoing TURB without an indwelling, pre-operative catheter/nephrostomy/DJ and a negative pre-operative urinary culture.-
dc.language.isoen-
dc.publisherSPRINGER-
dc.rightsThe Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021-
dc.subject.otherTURB-
dc.subject.otherAMP-
dc.subject.otherMicrobial resistance-
dc.subject.otherRCT-
dc.subject.otherFever-
dc.subject.otherAntimicrobial stewardship-
dc.titleA randomized trial regarding antimicrobial prophylaxis (AMP) in transurethral resection of bladder tumor (TURB)-
dc.typeJournal Contribution-
dc.identifier.epage3844-
dc.identifier.issue10-
dc.identifier.spage3839-
dc.identifier.volume39-
local.format.pages6-
local.bibliographicCitation.jcatA1-
dc.description.notesBaten, E (corresponding author), Associatie Urol Hageland, Kapellekensweg 10, Kessel Lo, Belgium.; Baten, E (corresponding author), Univ Hasselt, Martelarenlaan 45, B-3050 Hasselt, Belgium.-
dc.description.notesEvert.baten@gmail.com-
dc.description.otherBaten, E (corresponding author), Associatie Urol Hageland, Kapellekensweg 10, Kessel Lo, Belgium ; Univ Hasselt, Martelarenlaan 45, B-3050 Hasselt, Belgium. Evert.baten@gmail.com-
local.publisher.placeONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1007/s00345-021-03694-6-
dc.identifier.isiWOS:000639060800002-
dc.identifier.eissn1433-8726-
local.provider.typewosris-
local.uhasselt.uhpubyes-
local.description.affiliation[Baten, E.; Slabbert, K.] Associatie Urol Hageland, Kapellekensweg 10, Kessel Lo, Belgium.-
local.description.affiliation[Van der Aa, F.; van Renterghem, K.] Univ Hosp Leuven, Dept Urol, Herestr 49, B-3000 Leuven, Belgium.-
local.description.affiliation[Goethuys, H.] ZOL Genk, Genk, Belgium.-
local.description.affiliation[Arijs, I] VIB, Ctr Canc Biol, B-3000 Leuven, Belgium.-
local.description.affiliation[Baten, E.; van Renterghem, K.] Univ Hasselt, Martelarenlaan 45, B-3050 Hasselt, Belgium.-
local.description.affiliation[van Renterghem, K.] Jessa Ziekenhuis, Dient Urol, Salvatorstr 20, B-3500 Hasselt, Belgium.-
local.uhasselt.internationalno-
item.fulltextWith Fulltext-
item.contributorBATEN, Evert-
item.contributorVan der Aa, F.-
item.contributorGOETHUYS, Hans-
item.contributorSlabbert, K.-
item.contributorARIJS, Ingrid-
item.contributorVAN RENTERGHEM, Koenraad-
item.fullcitationBATEN, Evert; Van der Aa, F.; GOETHUYS, Hans; Slabbert, K.; ARIJS, Ingrid & VAN RENTERGHEM, Koenraad (2021) A randomized trial regarding antimicrobial prophylaxis (AMP) in transurethral resection of bladder tumor (TURB). In: World Journal of Urology, 39 (10), p. 3839-3844.-
item.accessRightsRestricted Access-
item.validationecoom 2022-
crisitem.journal.issn0724-4983-
crisitem.journal.eissn1433-8726-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
s00345-021-03694-6.pdf
  Restricted Access
Published version561.65 kBAdobe PDFView/Open    Request a copy
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.